Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy

Heart

Volumn 85, Issue 6, 2001, Pages 692-696

  Acar, P ^a   Iserin, L ^a   Bonnet, D ^a   Sidi, D ^a   Kachaner, J ^a   Merlet, P ^b   Syrota, A ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b DIF   (France)

Author keywords

Cardiomyopathy; Children; MIBG; Noradrenaline; Single photon imaging

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; NORADRENALIN;

ADRENERGIC NERVE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HEART DILATATION; HEART INNERVATION; HEART SCINTISCANNING; HEART TRANSPLANTATION; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034768942     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.6.692     Document Type: Article

References (44)

1. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
2. The determinants of clinical response and survival in patients with congestive heart failure treated with enalapril
3. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration
4. Predictors of total mortality and sudden death in mild to moderate heart failure
5. Plasma norepinephrine levels in infants and children with congestive heart failure
6. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - Implications for clinical studies
7. Prognostic value of cardiac MIBG imaging in patients with congestive heart failure
8. MIBG imaging provides the strongest prognostic information in patients with idiopathic dilated cardiomyopathy
9. 2 and prognosis
10. A quantitative evaluation of heart size measurements from chest roentgenograms
11. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
12. Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure
13. Myocardial noradrenaline content: A factor not considered up to now for the prognosis of patients with dilated cardiomyopathy
14. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure
15. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity
16. Adverse consequences of high sympathetic nervous activity in the failing human heart
17. Norepinephrine metabolism in hypertrophied rat heart
18. Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig
19. Uptake of catecholamines by human cardiac muscle in vitro
20. Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload
21. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine
22. Evidence for reduction of norepinephrine uptake sites in the failing human heart
23. Sympathetic nerve function in congestive heart failure
24. Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart
25. Decreased adrenergic neuronal uptake activity in experimental right heart failure
26. β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms
27. Transmural heterogeneity of norepinephrine in failing human hearts
28. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure
29. Idiopathic dilated cardiomyopathy in the young: Clinical profile and natural history
30. Dilated cardiomyopathy in infants and children
31. The clinical course of primary myocardial disease in infants and children
32. Clinical profile of congestive cardiomyopathy in children
33. Congestive cardiomyopathy in children
34. Clinical course of idiopathic dilated cardiomyopathy in children
35. Natural history of dilated cardiomyopathy in children
36. Prognostic features of children with idiopathic dilated cardiomyopathy
37. Idiopathic nonobstructive cardiomyopathy in children
38. The child with dilated cardiomyopathy: Prognostic considerations and management decisions
39. Infantile dilated cardiomyopathy
40. Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload
41. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
42. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
43. A randomized trial of β-blockade in heart failure
44. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure